Automated cannabis testing market is expected to show significant growth over the forecast period due to the increasing adoption of automated cannabis testing among people and prescribers as automated cannabis testing can be used without much of the concern of feeling of discomfort. Growing government legalizations on the distribution of medical marijuana are also expected to fuel the growth of automated cannabis testing market. Furthermore, rise in the need of treatment among the geriatric population for chronic diseases, and the rising number of medical marijuana clubs which generally promote the quality associated with medical marijuana and awareness programs conducted by public and private associations are some of the other factors contributing in driving the growth of the global automated cannabis testing market. Stringent regulations are expected to hamper the growth of the global automated cannabis testing market over the forecast period. In addition, the lack of standardization throughout the industry is a challenge that may hinder the growth of the automated cannabis testing market during the forecast period.
Automated Cannabis Testing Market: Overview
The global automated cannabis testing market is anticipated to witness moderate growth over the forecast period. As the automated cannabis testing market matures, the local and state legislation are becoming more stringent. Also, the legalized automated cannabis testing market has opened up a new world of opportunities and challenges for analytical scientists. It is also observed that there is an increase in the prevalence of cannabis used in the U.S. due to ongoing changes in legalization in some states. Some of the end users for cannabis analyzers include consumers, regulators, laboratories, and others.
Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9066
Automated Cannabis Testing Market: Regional Outlook
North America automated cannabis testing market is anticipated to hold maximum market share in the global automated cannabis testing market due to the spending on research activities is more in North America region when compared with the global health spending. Similarly, Europe automated cannabis testing market is expected to show a moderate growth owing to acquisition and collaboration of the leading manufacturers. The Middle East & Africa automated cannabis testing market is projected to account minimum share in the global automated cannabis testing market as very few countries in the region have regularized medical marijuana laws. China automated cannabis testing market is expected to be a competitive market with many regional players involved in the automated cannabis testing market.
Automated Cannabis Testing Market: Key Players
Examples of some of the key players in the global automated cannabis testing market are Medicinal Genomics Corp., Hamilton Company, PerkinElmer Inc., Agilent Technologies, Inc., Todaro robotics, QUANTUM ANALYTICS, Shimadzu Scientific Instruments, and others. In order to gain market share in the global automated cannabis testing market, the key players re majorly focusing to get product approvals in order to expand their geographical presence globally. Furthermore, the adoption of organic and inorganic market strategies by automated cannabis testing market players helps the automated cannabis testing market to grow at a moderate growth rate.
The report covers exhaustive analysis on:
- Automated Cannabis Testing Market Segments
- Automated Cannabis Testing Market Dynamics
- Market Size
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
The regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
- China
- Japan
- The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-9066
The global automated cannabis testing market is segmented by product type, application, end user, and region:
Based on product type, the global automated cannabis testing market is segmented into:
- Chromatography Based Analyzer
- Spectroscopy Based Analyzer
Based on application, the global automated cannabis testing market is segmented into:
- Pain Management
- Seizures
- Sclerosis
- Others
Based on the end user, the global automated cannabis testing market is segmented into:
- Consumers
- Regulators
- Laboratories
- Others
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:
Insulin Pens Market Size: The global insulin pens market is expected to grow at a CAGR of 6.5% during the period 2023 to 2033. The market is holding a valuation of US$ 35 billion as of 2023.
Insulin Delivery Pens Market Share: The global insulin delivery pens market is expected to reach a valuation of US$ 22.4 Billion by the end of 2022, and further expand at a CAGR of 8.0% to reach a valuation of US$ 48.6 Billion by the end of 2032.
CIS Insulin Market Growth: The global CIS insulin market is expected to reach US$ 465 Million by 2022. An increasing number of diabetic patients are estimated to further increase the demand for CIS insulin. During the forecast period ranging from 2022-2032
About FMI:
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
